Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
15-Sep-2025 | 54.05 | 54.49 | 53.37 | 53.56 | 11,751 | 13,63,69,554.85 | 10,54,773 |
16-Sep-2025 | 53.8 | 54.25 | 53.22 | 53.33 | 9,932 | 10,84,57,994.3 | 7,41,599 |
17-Sep-2025 | 53.6 | 55.4 | 53.17 | 53.76 | 21,299 | 28,19,97,111.87 | 14,05,102 |
18-Sep-2025 | 54.04 | 55.5 | 53.8 | 53.99 | 18,822 | 26,33,71,616.25 | 14,07,273 |
19-Sep-2025 | 54 | 54.7 | 53.71 | 54.14 | 11,775 | 14,98,62,371.25 | 7,42,265 |
22-Sep-2025 | 54.19 | 54.2 | 53.01 | 53.18 | 12,449 | 11,11,16,747.23 | 8,47,305 |
23-Sep-2025 | 53.48 | 53.48 | 51.62 | 51.97 | 16,884 | 13,40,22,145.93 | 9,38,692 |
24-Sep-2025 | 51.81 | 52.05 | 50.54 | 50.81 | 12,878 | 11,99,40,974.67 | 8,09,559 |
25-Sep-2025 | 50.5 | 51.22 | 50 | 50.19 | 14,720 | 10,98,01,226.61 | 7,76,617 |
26-Sep-2025 | 49.75 | 49.77 | 48.36 | 48.87 | 20,623 | 13,94,71,660.8 | 10,47,940 |
29-Sep-2025 | 49 | 49.25 | 47.79 | 48.07 | 15,899 | 10,36,33,765.1 | 9,34,063 |
30-Sep-2025 | 48.36 | 48.81 | 47.58 | 47.85 | 13,066 | 8,92,05,815.7 | 6,22,448 |
01-Oct-2025 | 48.13 | 48.94 | 47.78 | 48.81 | 13,664 | 10,00,09,503.47 | 7,48,780 |
03-Oct-2025 | 49 | 49.43 | 48.22 | 49.23 | 16,795 | 11,33,31,025.31 | 7,81,039 |
06-Oct-2025 | 49.46 | 49.46 | 48.55 | 48.73 | 10,869 | 6,77,33,488.45 | 6,88,157 |
07-Oct-2025 | 48.67 | 48.92 | 48.22 | 48.5 | 10,622 | 6,59,38,529.16 | 5,21,184 |
08-Oct-2025 | 48.44 | 48.69 | 48 | 48.09 | 8,440 | 5,48,87,987.44 | 4,60,833 |
09-Oct-2025 | 48.14 | 48.55 | 47.7 | 47.91 | 10,675 | 8,16,94,733.63 | 5,47,498 |
10-Oct-2025 | 47.97 | 50.38 | 47.9 | 49.85 | 25,313 | 24,49,73,712.97 | 15,98,106 |
13-Oct-2025 | 49.16 | 49.45 | 48.57 | 48.95 | 15,576 | 7,48,25,103.67 | 6,05,924 |
The venture will follow a 50:50 shareholding structure, with Morepen Medipath indirectly holding a 30% stake.
With this approval, Morepen Laboratories aims to strengthen its presence in China, which is one of the world’s largest pharmaceutical markets.
Developed from scratch, this drug offers an inexpensive and superior alternative to current treatments, making it accessible to hundreds of millions of patients.
Here are some of the stocks that may see significant price movement today: Tata Motors, ITC, Kalyan Jewellers, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
